Suchergebnisse - (Person:"Adhikari, Nilanjan")

PubPharm (22)

1

Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors : a cross-validated approach of ligand-based and structure-based molecular modeling studies

enthalten in: Journal of biomolecular structure & dynamics | 2024

von Banerjee, S. | Kejriwal, S. | Ghosh, B. | +3

2

An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)

enthalten in: Expert opinion on therapeutic patents | 2023

von Banerjee, S. | Baidya, S. | Adhikari, N. | +1

3

Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer

enthalten in: European journal of medicinal chemistry | 2022

von Pulya, S. | Patel, T. | Paul, M. | +6

4

Synthesis, anticancer activity, SAR and binding mode of interaction studies of substituted pentanoic acids : part II

enthalten in: Future medicinal chemistry | 2022

von Datta, S. | Halder, A. | Adhikari, N. | +3

5

Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model

enthalten in: Bioorganic chemistry | 2021

von Routholla, G. | Pulya, S. | Patel, T. | +7

6

Ligand-based design of anticancer MMP2 inhibitors : a review

enthalten in: Future medicinal chemistry | 2021

von Sanyal, S. | Amin, S. | Adhikari, N. | +1

7

Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors

enthalten in: Bioorganic chemistry | 2021

von Routholla, G. | Pulya, S. | Patel, T. | +5

8

Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer : Comparative SAR/QSAR assessment on steroidal aromatase inhibitors

enthalten in: European journal of medicinal chemistry | 2020

von Adhikari, N. | Baidya, S. | Jha, T.

9

Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer : A minireview

enthalten in: European journal of medicinal chemistry | 2020

von Mondal, S. | Adhikari, N. | Banerjee, S. | +2

ErratumIn: Eur J Med Chem. 2020 Nov 1;205:112642. - PMID 32750565

10

Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents : A review

enthalten in: European journal of medicinal chemistry | 2020

von Sarkar, R. | Banerjee, S. | Amin, S. | +2